Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
chlorhydrate de dopamine 40 mg/mL, ampoule de 5 mL de concentré pour perfusion |
Is a |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de dopamine 160 mg/mL, ampoule de 5 mL de concentré pour perfusion |
Is a |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de dopamine 40 mg/mL, seringue préremplie de 5 mL de solution pour injection |
Is a |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de dopamine 40 mg/mL, seringue préremplie de 10 mL de solution pour injection |
Is a |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride in glucose 400mg/250mL infusion |
Is a |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride in glucose 800mg/250mL infusion |
Is a |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de dopamine 40 mg/mL, ampoule de 5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de dopamine 160 mg/mL, ampoule de 5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de dopamine 40 mg/mL, seringue préremplie de 5 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
chlorhydrate de dopamine 40 mg/mL, seringue préremplie de 10 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride 40mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride 80mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride 160mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride 800mg/glucose infusion solution 250mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride 40mg/mL injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride 80mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride 40mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride 40mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Dopamine hydrochloride 80mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely dopamine hydrochloride 800 milligram/5 milliliter conventional release solution for infusion ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 800 milligram/5 milliliter conventional release solution for infusion ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 200 milligram/5 milliliter conventional release solution for infusion ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 200 milligram/5 milliliter conventional release solution for infusion ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 400 milligram/10 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 400 milligram/10 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 200 milligram/5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 200 milligram/5 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Dopamine hydrochloride 40 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Dopamine hydrochloride 40 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Dopamine hydrochloride 40 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Dopamine hydrochloride 40 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 40 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 40 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dopamine hydrochloride |
Inferred relationship |
Some |
1 |